chr3-175096823-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_207015.3(NAALADL2):ā€‹c.77A>Gā€‹(p.Asp26Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000184 in 1,599,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00011 ( 0 hom., cov: 31)
Exomes š‘“: 0.00019 ( 0 hom. )

Consequence

NAALADL2
NM_207015.3 missense

Scores

3
3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.08
Variant links:
Genes affected
NAALADL2 (HGNC:23219): (N-acetylated alpha-linked acidic dipeptidase like 2) Predicted to enable metalloexopeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within response to bacterium. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
NAALADL2-AS3 (HGNC:41014): (NAALADL2 antisense RNA 3)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.13048232).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NAALADL2NM_207015.3 linkuse as main transcriptc.77A>G p.Asp26Gly missense_variant 2/14 ENST00000454872.6 NP_996898.2
NAALADL2-AS3NR_046390.1 linkuse as main transcriptn.111-15621T>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NAALADL2ENST00000454872.6 linkuse as main transcriptc.77A>G p.Asp26Gly missense_variant 2/141 NM_207015.3 ENSP00000404705 P1Q58DX5-1
NAALADL2-AS3ENST00000453180.5 linkuse as main transcriptn.111-15621T>C intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151986
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000127
AC:
29
AN:
229162
Hom.:
0
AF XY:
0.000137
AC XY:
17
AN XY:
123788
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000631
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000252
Gnomad OTH exome
AF:
0.000181
GnomAD4 exome
AF:
0.000191
AC:
277
AN:
1447898
Hom.:
0
Cov.:
29
AF XY:
0.000197
AC XY:
142
AN XY:
719234
show subpopulations
Gnomad4 AFR exome
AF:
0.0000303
Gnomad4 AMR exome
AF:
0.0000713
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000239
Gnomad4 OTH exome
AF:
0.000150
GnomAD4 genome
AF:
0.000112
AC:
17
AN:
151986
Hom.:
0
Cov.:
31
AF XY:
0.0000674
AC XY:
5
AN XY:
74218
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000235
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000167
Hom.:
0
Bravo
AF:
0.000102
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.000133
AC:
16

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 30, 2021The c.77A>G (p.D26G) alteration is located in exon 2 (coding exon 2) of the NAALADL2 gene. This alteration results from a A to G substitution at nucleotide position 77, causing the aspartic acid (D) at amino acid position 26 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.025
.;T
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.90
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.13
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
.;L
MutationTaster
Benign
0.85
N
PrimateAI
Benign
0.47
T
PROVEAN
Pathogenic
-7.0
D;N
REVEL
Benign
0.17
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.64
.;P
Vest4
0.62
MVP
0.56
MPC
0.0048
ClinPred
0.17
T
GERP RS
5.7
Varity_R
0.38
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199754631; hg19: chr3-174814613; API